Helicobacter Pylori Cag A antibodies and their clinical implications: Correlation of Helicobacter pylori CagA antibodies with treatment resistance, bleeding ulcer and gastric cancer - Softcover
Synopsis
It has been estimated that half the world’s population carries H. pylori.Most infected people remain asymptomatic during their lifetime, and only about 15% develop gastroduodenal disorders. This implies near perfect adaptation to the niche and an ability to evade the human immune response. Of those infected, about 10% develop peptic ulceration, roughly 1% develop gastric adenocarcinoma and less than 0.1% MALT (mucosa-associated lymphoid tissue lymphoma. Infection with H pylori elicits a systemic, strong and polymorphic humoral immune response. CagA is the important pathologic marker with a high immunogenic response.The highest titers of cag A antibodies (more than 100 arbU/ml) in the study realised by Ilie et al in 2011, was found for resistance to first line therapy, bleeding gastroduodenal ulcers, NSAID negative and gastric cancer. We recommend verification of H. pylori eradication to cag A positive patients one month after completing the treatment. This book will raise the interest of gastroenterologists,general practitioners,microbiologists,immunologists and last but not least medical students.
"synopsis" may belong to another edition of this title.
About the Author
ˇ Specialist in gastroenterology and internal medicineˇ Assistant Professor of Gastroenterology, UMF Carol Davila ˇ Ph D in gastroenterologyˇ Master in medical biology
"About this title" may belong to another edition of this title.
- PublisherLAP LAMBERT Academic Publishing
- Publication date2014
- ISBN 10 3659526630
- ISBN 13 9783659526633
- BindingPaperback
- Number of pages112
Buy New
Learn more about this copy
US$ 26.01
Shipping:
US$ 3.99
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
Helicobacter Pylori Cag A antibodies and their clinical implications: Correlation of Helicobacter pylori CagA antibodies with treatment resistance, bleeding ulcer and gastric cancer
Published by
LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
Softcover
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # ABLIING23Mar3113020290954
Quantity: 19 available
Stock Image
Helicobacter Pylori Cag A antibodies and their clinical implications Correlation of Helicobacter pylori CagA antibodies with treatment resistance, bleeding ulcer and gastric cancer
Published by
LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
PAP
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 5 out of 5 stars
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659526633
Quantity: Over 20 available
Stock Image
Helicobacter Pylori Cag a Antibodies and Their Clinical Implications
Published by
LAP Lambert Academic Publishing, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
Softcover
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783659526633_lsuk
Quantity: Over 20 available
Stock Image
Helicobacter Pylori Cag A antibodies and their clinical implications Correlation of Helicobacter pylori CagA antibodies with treatment resistance, bleeding ulcer and gastric cancer
Published by
LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
PAP
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Seller rating 5 out of 5 stars
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659526633
Quantity: Over 20 available
Stock Image
Helicobacter Pylori Cag a Antibodies and Their Clinical Implications
Published by
LAP Lambert Academic Publishing 2014-04, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
PF
Seller: Chiron Media, Wallingford, United Kingdom
Seller rating 5 out of 5 stars
PF. Condition: New. Seller Inventory # 6666-IUK-9783659526633
Quantity: 10 available
Seller Image
Helicobacter Pylori Cag A antibodies and their clinical implications
Published by
LAP LAMBERT Academic Publishing Apr 2014, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
Taschenbuch
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -It has been estimated that half the world s population carries H. pylori.Most infected people remain asymptomatic during their lifetime, and only about 15% develop gastroduodenal disorders. This implies near perfect adaptation to the niche and an ability to evade the human immune response. Of those infected, about 10% develop peptic ulceration, roughly 1% develop gastric adenocarcinoma and less than 0.1% MALT (mucosa-associated lymphoid tissue lymphoma. Infection with H pylori elicits a systemic, strong and polymorphic humoral immune response. CagA is the important pathologic marker with a high immunogenic response.The highest titers of cag A antibodies (more than 100 arbU/ml) in the study realised by Ilie et al in 2011, was found for resistance to first line therapy, bleeding gastroduodenal ulcers, NSAID negative and gastric cancer. We recommend verification of H. pylori eradication to cag A positive patients one month after completing the treatment. This book will raise the interest of gastroenterologists,general practitioners,microbiologists,immunologists and last but not least medical students. 112 pp. Englisch. Seller Inventory # 9783659526633
Quantity: 2 available
Seller Image
Helicobacter Pylori Cag A antibodies and their clinical implications : Correlation of Helicobacter pylori CagA antibodies with treatment resistance, bleeding ulcer and gastric cancer
Published by
LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
Taschenbuch
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - It has been estimated that half the world s population carries H. pylori.Most infected people remain asymptomatic during their lifetime, and only about 15% develop gastroduodenal disorders. This implies near perfect adaptation to the niche and an ability to evade the human immune response. Of those infected, about 10% develop peptic ulceration, roughly 1% develop gastric adenocarcinoma and less than 0.1% MALT (mucosa-associated lymphoid tissue lymphoma. Infection with H pylori elicits a systemic, strong and polymorphic humoral immune response. CagA is the important pathologic marker with a high immunogenic response.The highest titers of cag A antibodies (more than 100 arbU/ml) in the study realised by Ilie et al in 2011, was found for resistance to first line therapy, bleeding gastroduodenal ulcers, NSAID negative and gastric cancer. We recommend verification of H. pylori eradication to cag A positive patients one month after completing the treatment. This book will raise the interest of gastroenterologists,general practitioners,microbiologists,immunologists and last but not least medical students. Seller Inventory # 9783659526633
Quantity: 1 available
Seller Image
Helicobacter Pylori Cag A antibodies and their clinical implications
Published by
LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659526630
ISBN 13: 9783659526633
New
Softcover
Seller: moluna, Greven, Germany
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # 5162532
Quantity: Over 20 available